To assess whether Gal-9 expression was correlated with the survival of patients with multiple myeloma, we evaluated patient survival rates in relation to Gal-9 expression by Kaplan–Meier analysis (Figure 4A). The gene discussed is LGALS9; the disease is plasma cell myeloma.